THE INFLUENCE OF INFORMATION ON DRUG-RESISTANCE ON PROTOCOL DESIGN - THE HENRY-KAPLAN-MEMORIAL-LECTURE, INTERNATIONAL-CONFERENCE ON MALIGNANT-LYMPHOMAS, 6-9 JUNE 1990, LUGANO, SWITZERLAND

被引:27
作者
DEVITA, VT
机构
[1] MEmorial Sloan-Kettering Cancer Center, New York, N.Y.
关键词
D O I
10.1093/oxfordjournals.annonc.a057892
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:93 / 106
页数:14
相关论文
共 90 条
[1]   16-WEEK DOSE-INTENSE CHEMOTHERAPY IN THE ADJUVANT TREATMENT OF BREAST-CANCER [J].
ABELOFF, MD ;
BEVERIDGE, RA ;
DONEHOWER, RC ;
FETTING, JH ;
DAVIDSON, NE ;
GORDON, GG ;
WATERFIELD, WC ;
DAMRON, DJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (07) :570-574
[2]  
AISNER J, 1988, P AN M AM SOC CLIN, V7, P27
[3]   THE BASIS OF MULTIDRUG RESISTANCE IN MAMMALIAN-CELLS - HOMOLOGY WITH BACTERIAL TRANSPORT [J].
AMES, GF .
CELL, 1986, 47 (03) :323-324
[4]  
Antman K, 1987, Important Adv Oncol, P221
[5]   THE GENE ENCODING MULTIDRUG RESISTANCE IS INDUCED AND EXPRESSED AT HIGH-LEVELS DURING PREGNANCY IN THE SECRETORY EPITHELIUM OF THE UTERUS [J].
ARCECI, RJ ;
CROOP, JM ;
HORWITZ, SB ;
HOUSMAN, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4350-4354
[6]   DETECTION OF P-GLYCOPROTEIN IN OVARIAN-CANCER - A MOLECULAR MARKER ASSOCIATED WITH MULTIDRUG RESISTANCE [J].
BELL, DR ;
GERLACH, JH ;
KARTNER, N ;
BUICK, RN ;
LING, V .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (03) :311-315
[7]  
BIEDLER JL, 1970, CANCER RES, V30, P1174
[8]   NATURAL HISTORY OF UNTREATED BREAST CANCER (1805-1933) - COMPARISON OF UNTREATED AND TREATED CASES ACCORDING TO HISTOLOGICAL GRADE OF MALIGNANCY [J].
BLOOM, HJG ;
HARRIES, EJ ;
RICHARDSON, WW .
BRITISH MEDICAL JOURNAL, 1962, (5299) :213-&
[9]   PRIMARY CHEMOTHERAPY TO AVOID MASTECTOMY IN TUMORS WITH DIAMETERS OF 3 CENTIMETERS OR MORE [J].
BONADONNA, G ;
VERONESI, U ;
BRAMBILLA, C ;
FERRARI, L ;
LUINI, A ;
GRECO, M ;
BARTOLI, C ;
DEYOLDI, GC ;
ZUCALI, R ;
RILKE, F ;
ANDREOLA, S ;
SILVESTRINI, R ;
DIFRONZO, G ;
VALAGUSSA, P .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (19) :1539-1545
[10]   ALTERNATING NON-CROSS-RESISTANT COMBINATION CHEMOTHERAPY OR MOPP IN STAGE-IV HODGKINS-DISEASE - A REPORT OF 8-YEAR RESULTS [J].
BONADONNA, G ;
VALAGUSSA, P ;
SANTORO, A .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (06) :739-746